To further explore the efficacy of CKI on liver fibrosis and related mechanism, we established CCl4‐induced chronic liver fibrosis models (Figure 1A) and MCD diet‐induced NASH model (Figure 1C). The gene discussed is CHKA; the disease is metabolic dysfunction-associated steatohepatitis.